JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
Hain Celestial
HAIN
$47.2M
| $3.89M | ﹤0.01% |
91,790
-43,186
| -32% | -$1.71M |
2013 Q2
18 quarters
|
|
2752
Open Text
OTEX
$5.38B
| $3.88M | ﹤0.01% |
108,866
-128,514
| -54% | -$4.29M |
2015 Q4
8 quarters
|
|
|
P
2753
Everpure Inc
P
$46.7B
| $3.87M | ﹤0.01% |
244,285
+121,478
| +99% | +$2.02M |
2015 Q4
8 quarters
|
|
|
VMW
2754
PUT
DELISTED
VMware, Inc
VMW
| $3.87M | ﹤0.01% |
+30,900
| New | +$3.71M |
2017 Q4
0 quarters
|
|
2755
Dine Brands
DIN
$379M
| $3.87M | ﹤0.01% |
76,296
-10,030
| -12% | -$468K |
2013 Q2
18 quarters
|
|
2756
Teekay
TK
$1.3B
| $3.87M | ﹤0.01% |
415,071
+255,204
| +160% | +$2.21M |
2015 Q1
11 quarters
|
|
2757
Designer Brands
DBI
$310M
| $3.87M | ﹤0.01% |
180,611
+112,103
| +164% | +$2.3M |
2015 Q1
11 quarters
|
|
|
RENX
2758
DELISTED
RELX N.V.
RENX
| $3.87M | ﹤0.01% |
167,559
+586
| +0.4% | +$13.2K |
2013 Q2
18 quarters
|
|
|
OSB
2759
DELISTED
Norbord Inc.
OSB
| $3.86M | ﹤0.01% |
114,288
+94,288
| +471% | +$3.37M |
2016 Q3
5 quarters
|
|
2760
Comtech Telecommunications
CMTL
$39.5M
| $3.86M | ﹤0.01% |
174,403
+31,772
| +22% | +$677K |
2013 Q2
18 quarters
|
|
2761
Tower Semiconductor
TSEM
$27.2B
| $3.85M | ﹤0.01% |
113,025
+32,782
| +41% | +$1.09M |
2015 Q4
8 quarters
|
|
|
QHC
2762
DELISTED
Quorum Health Corporation
QHC
| $3.84M | ﹤0.01% |
615,861
-200,073
| -25% | -$1M |
2016 Q2
6 quarters
|
|
2763
Black Stone Minerals
BSM
$3.1B
| $3.84M | ﹤0.01% |
214,001
+94,799
| +80% | +$1.67M |
2015 Q2
10 quarters
|
|
2764
State Street SPDR S&P Health Care Equipment ETF
XHE
$189M
| $3.84M | ﹤0.01% |
59,613
+162
| +0.3% | +$10.4K |
2017 Q2
2 quarters
|
|
|
MZTI
2765
The Marzetti Company
MZTI
$2.72B
| $3.84M | ﹤0.01% |
29,702
-17,162
| -37% | -$2.17M |
2014 Q3
13 quarters
|
|
2766
Enpro
NPO
$7.04B
| $3.84M | ﹤0.01% |
41,022
+11,158
| +37% | +$945K |
2015 Q4
8 quarters
|
|
2767
PUT
Duke Energy
DUK
$89B
| $3.83M | ﹤0.01% |
45,500
+30,000
| +194% | +$2.62M |
2017 Q1
3 quarters
|
|
2768
First Trust Emerging Markets AlphaDEX Fund
FEM
$813M
| $3.83M | ﹤0.01% |
137,031
+43,394
| +46% | +$1.19M |
2016 Q3
5 quarters
|
|
|
BOLD
2769
DELISTED
Audentes Therapeutics, Inc
BOLD
| $3.82M | ﹤0.01% |
122,144
+44,944
| +58% | +$1.23M |
2016 Q3
5 quarters
|
|
2770
Vanguard Total World Stock ETF
VT
$81.2B
| $3.81M | ﹤0.01% |
51,277
+5,482
| +12% | +$398K |
2013 Q4
16 quarters
|
|
2771
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.55B
| $3.8M | ﹤0.01% |
64,938
-750
| -1% | -$42.7K |
2013 Q2
18 quarters
|
|
2772
CALL
Crown Castle
CCI
$28.3B
| $3.8M | ﹤0.01% |
34,200
-18,600
| -35% | -$2.01M |
2017 Q2
2 quarters
|
|
2773
PUT
Travelers Companies
TRV
$75.2B
| $3.78M | ﹤0.01% |
27,900
-25,000
| -47% | -$3.3M |
2017 Q3
1 quarter
|
|
|
LKSD
2774
DELISTED
LSC Communications, Inc.
LKSD
| $3.77M | ﹤0.01% |
248,749
+90,679
| +57% | +$1.44M |
2016 Q4
4 quarters
|
|
|
GHL
2775
DELISTED
Greenhill & Co., Inc.
GHL
| $3.76M | ﹤0.01% |
193,028
-51,206
| -21% | -$953K |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.